Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Gains from Investment Securities (2021 - 2022)

Scilex Holding (SCLX) posted quarterly Gains from Investment Securities of -$68400.0 for Q3 2022, down 105.88% year-over-year from $1.2 million in Q3 2021, and up 97.3% quarter-over-quarter from -$2.5 million in Q2 2022.

Scilex Holding (SCLX) Gains from Investment Securities (2021 - 2022) Analysis & Trends

Scilex Holding's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$68400.0 for Q3 2022.

  • In Q3 2022, Gains from Investment Securities fell 105.88% year-over-year to -$68400.0; the TTM figure through Sep 2022 stood at -$3.7 million (changed N/A YoY), while the FY2021 annual figure was -$4.4 million, changed N/A from the prior year.
  • Gains from Investment Securities for Q3 2022 stood at -$68400.0, up from -$2.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $1.2 million in Q3 2021, with the low at -$4.1 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn

Historic Data

Download Data
DateValue
Sep 30, 2022 -68,400.00
Sep 30, 2022 -68,400.00
Jun 30, 2022 -2.53 Mn
Jun 30, 2022 -2.53 Mn
Mar 31, 2022 410,400.00
Mar 31, 2022 410,400.00
Dec 31, 2021 -1.50 Mn
Dec 31, 2021 -1.50 Mn
Sep 30, 2021 1.16 Mn
Sep 30, 2021 1.16 Mn
Jun 30, 2021 68,400.00
Jun 30, 2021 68,400.00
Mar 31, 2021 -4.10 Mn
Mar 31, 2021 -4.10 Mn